Breath Hold Techniques for Stomach Cancer

(INEX-RT P Trial)

This trial explores a new method of using radiation therapy for stomach cancer patients. The aim is to enhance tumor targeting while safeguarding nearby organs by having patients hold their breath in various ways during treatment sessions. This technique might enable doctors to increase the radiation dose to the cancer while protecting nearby organs. Patients with stomach cancer whose tumors are near sensitive organs and who can hold their breath during treatment may be suitable candidates for this study.

As an unphased trial, this study provides patients the chance to contribute to innovative research that could improve future cancer treatments.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that radiation therapy (RT), such as the type used in the INEX RT treatment, is generally well-tolerated by stomach cancer patients. Studies on similar radiation methods have demonstrated their effectiveness in targeting cancer cells while protecting healthy tissue. Side effects, or unwanted reactions, can occur, but they are often mild and manageable. Common side effects may include fatigue or skin irritation.

Researchers are excited about the Breath Hold Techniques for Stomach Cancer trial because it explores an innovative method to potentially improve radiation therapy outcomes. Unlike traditional treatments that expose healthy tissues to radiation, this technique aims to limit damage by precisely targeting cancer cells while the patient holds their breath. This could lead to fewer side effects and improved quality of life for patients undergoing radiation therapy. By enhancing the precision of radiation delivery, this approach may also increase the effectiveness of the treatment, offering new hope for those battling stomach cancer.

Research has shown that radiation therapy (RT) can effectively treat stomach cancer, particularly by controlling symptoms such as bleeding and pain. In past studies, more than two-thirds of patients who received RT experienced benefits. This trial will explore techniques like INEX RT, which aim to enhance radiation delivery, allowing a higher dose to cancer cells while safeguarding nearby healthy organs. Special breath-holding methods may increase treatment precision, focusing more accurately on the cancer. Although RT alone might not significantly boost long-term survival, it plays a crucial role in managing symptoms and improving quality of life.⁶⁷⁸⁹¹⁰